Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study.
D001088:Arabinonucleotides / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D001084:Vidarabine Phosphate / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*
D001088:Arabinonucleotides; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate